1.Predictive Factors on Remission after Transsphenoidal Surgery for Prolactinomas.
Sung Min HUR ; Eun Jeong KOH ; Ha Young CHOI
Journal of Korean Neurosurgical Society 2002;32(4):312-317
OBJECTIVE: This study is designed to demonstrate the factors influencing on the the postoperative remission or recurrence after transsphenoidal approach(TSA) for treatment of the prolactinomas. METHODS:This study included 18 patients who underwent TSA. Pre- and post-operative magnetic resonance(MR) image, and serum prolactin levels were checked. Classification(Grade I-V, Stage 0-E) of the tumor were performed based on the preoperative MR image and intraoperative surgical finidngs. "Remission" was defined when normal serum prolactin level without amenorrhea, galactorrhea was noticed. "Recurrence" was defined when postoperative prolactin level was above 20ng/ml and amennorrhea, galactorrhea were presented. RESULTS: Patients were grade I in eight, grade II in six, grade III in three, and grade IV in one. Postoperative results showed remission in 13 and recurrence in five. Depending on preoperative serum prolactin levels, remission was achieved in 100% of patients under 100ng/ml, 83% of patients in 100-200ng/ml, and 50% of patients above 200ng/ml. Remission was noticed in 75.0% of grade I, 83.3% of grade II, 66.6% of grade III, and 0% of grade IV. Also, remission was presented in 80.0% of stage 0, 66.7% of stage A, 0% of Stage B. CONCLUSION: After TSA, remission could be achieved in patients with low preoperative serum prolactin level, small sized tumor, and less invasive tumor into the sellar floor. It is suggested that preoperative serum prolactin level, tumor size, and invasiveness of the tumor into the sellar floor are of value in prediction of the remission after TSA in patients with prolactinoma.
Amenorrhea
;
Female
;
Galactorrhea
;
Humans
;
Pregnancy
;
Prolactin
;
Prolactinoma*
;
Recurrence
2.Risperodone Induced Hyperprolactinemia and Its Clinical Complications.
Namjun PARK ; Jaenam BAE ; Minhee KANG ; Chuleung KIM
Korean Journal of Psychopharmacology 2003;14(1):35-39
OBJECT: Risperidone, unlike other atypical antipsychotics, is thought to elevate prolactin levels. This paper examines the relationship of risperidone-induced hyperprolactinemia and the sexual dysfunctions of the patients in the real clinical practice. METHODS: Forty nine patients (male 22, female 27) with 6 month-over risperidone medication were assigned and serum prolactin was assayed in serum by radioimmunometric assay. In the distinction of sex, six adverse events possibly associated with increased prolactin levels were determined by interviewing the patients (poor erection, ejaculatory dysfunction, galactorrhea, decreased libido, orgasmic dysfunction and obesity in male;amenorrhea, vaginal dryness, galactorrhea, decreased libido, orgasmic dysfunction and obesity in female). RESULTS: In 49 patients, thirty six patients (male 15;56%, female 21;95%) showed hyperprolactinemia and twenty two patients (male 13;48%, female 8;36%) had sexual side-effects. Both risperidone dosage per day and duration were not correlated with prolactin levels and adverse events. There was no significant direct correlation between serum prolactin levels and sexual adverse events. CONCLUSION: The risperidone-associated increase in serum prolactin levels was not significantly directly correlated with the emergence of possible prolactin-related adverse events in the real clinical practice. However, our results suggest that risperidone-induced hyperprolactinemia may play a role in sexual dysfunction of female patients.
Antipsychotic Agents
;
Female
;
Galactorrhea
;
Humans
;
Hyperprolactinemia*
;
Libido
;
Obesity
;
Orgasm
;
Pregnancy
;
Prolactin
;
Risperidone
3.Pituitary enlargement and Hyperprolactinemia in Primary Hypothyroidism: A Case Report.
Min Ki KIM ; Phil Za CHO ; Il Nam SUNWOO
Journal of the Korean Neurological Association 1990;8(1):198-202
A 29 year old woman came to the hospital due to headache, facial edema, amenorrhea and galactorrhea. On the lahoratory studies, not only hyperprolactinemia and pituitary enlargement, but also primary hypothyroidism were found. Symptomatic and radiological resolution could be achieved by the thyroid hormone replacement only. This case emphasizes the need for evaluation of thyroid status in patients vith presumptive prolacin producing pituitary tumors before initiation of the therapy for hyperprolactinemia.
Adult
;
Amenorrhea
;
Edema
;
Female
;
Galactorrhea
;
Headache
;
Humans
;
Hyperprolactinemia*
;
Hypothyroidism*
;
Pituitary Neoplasms
;
Pregnancy
;
Thyroid Gland
4.Resolution of Ziprasidone-Induced Hyperprolactinemia with Aripiprazole.
Sung Wan KIM ; Seung Hyun LEE ; Seon Young KIM ; Jae Min KIM ; Il Seon SHIN ; Jin Sang YOON
Korean Journal of Psychopharmacology 2009;20(2):106-110
Hyperprolactinemia is a frequent, serious adverse effect of antipsychotics. Ziprasidone seems to be less frequently associated with hyperprolactinemia than other antipsychotics. We report a case of 25-year-old woman who developed amenorrhea, galactorrhea, and hyperprolactinemia while taking ziprasidone, which resolved with the addition of aripiprazole. To our best knowledge, this is the first report that adjunctive aripiprazole attenuated ziprasidoneinduced hyperprolactinemia.
Adult
;
Amenorrhea
;
Antipsychotic Agents
;
Female
;
Galactorrhea
;
Humans
;
Hyperprolactinemia
;
Piperazines
;
Pregnancy
;
Quinolones
;
Thiazoles
;
Aripiprazole
5.Microsurgical Transsphenoidal Approach for Pituitary Denomas.
Journal of Korean Neurosurgical Society 1976;5(2):195-208
3 cases of pituitary adenomas, two hormone-secreting adenomas, and one non-secreting chromophobe adenoma, were treated surgically by the sublabial transsphenoidal approach with use of surgical microscope and radiofluroscopic image intensification at the Dept. of Neurosurgery, Yonsei University Medical College. The 2 cases of hormone secreting adenomas were an eosinophilic microadenoma manifestating gigantism and a prolaction secreting adenoma with amenorrhea and galactorrhea. The simplicity of this technique, criteria for the treatment of the hormone secreting and non-secreting adenomas and their biologic behaviors were described and discussed with review of literatures.
Adenoma
;
Adenoma, Chromophobe
;
Amenorrhea
;
Eosinophils
;
Female
;
Galactorrhea
;
Gigantism
;
Neurosurgery
;
Pituitary Neoplasms
;
Pregnancy
6.Microsurgical Transsphenoidal Approach for Pituitary Denomas.
Journal of Korean Neurosurgical Society 1976;5(2):195-208
3 cases of pituitary adenomas, two hormone-secreting adenomas, and one non-secreting chromophobe adenoma, were treated surgically by the sublabial transsphenoidal approach with use of surgical microscope and radiofluroscopic image intensification at the Dept. of Neurosurgery, Yonsei University Medical College. The 2 cases of hormone secreting adenomas were an eosinophilic microadenoma manifestating gigantism and a prolaction secreting adenoma with amenorrhea and galactorrhea. The simplicity of this technique, criteria for the treatment of the hormone secreting and non-secreting adenomas and their biologic behaviors were described and discussed with review of literatures.
Adenoma
;
Adenoma, Chromophobe
;
Amenorrhea
;
Eosinophils
;
Female
;
Galactorrhea
;
Gigantism
;
Neurosurgery
;
Pituitary Neoplasms
;
Pregnancy
7.A Case of Hyperprolactinemia with Galactorrhea Induced by Carbamazepine.
Chun Hoon PARK ; Sun Young KIM ; Seung Hwan YOON ; Jong Yun LEE ; Yeon Kyung JUNG ; Im Seok KOH ; Phil Za CHO
Journal of the Korean Neurological Association 2007;25(3):381-382
Carbamazepine (CBZ) may alter the secretion of prolactin (PRL), however, there is no report about hyperprolactinemia with galactorrhea induced by CBZ medication. A 30-year-old woman presented with galactorrhea. She had been treated with CBZ for three years and hormonal study revealed increased serum PRL levels. Sella MRI showed no evidence of pituitary lesion. Two months after changing CBZ to oxcarbazepine, galatorrhea was improved and the serum PRL level was normalized.
Adult
;
Carbamazepine*
;
Female
;
Galactorrhea*
;
Humans
;
Hyperprolactinemia*
;
Magnetic Resonance Imaging
;
Pregnancy
;
Prolactin
8.Mixed Gangliocytoma-Pituitary Adenoma: A case report.
Dong Sug KIM ; Dae Hong SUH ; Mi Jin KIM ; O Lyong KIM
Korean Journal of Pathology 1998;32(2):138-141
The mixed gangliocytoma-pituitary adenoma is a very rare intracranial neoplasm, and it is frequently associated with endocrine symptoms; acromegaly, Cushing's disease, galactorrhea and amenorrhea. Morphologically it shows a mixture of gangliocytoma and pituitary adenoma in various proportions. In the area of gangliocytoma, there is no neoplastic glial component. The portion of pituitary adenoma consists mainly of chromophobe cells. There are three hypotheses in its histogenesis. We report a case of a 41 year-old lady presented with acromegaly and amenorrhea existing for 3 years. On magnetic resonance image, there is a dumbell-shaped mass in the sellar region. Histologically it showed typical features of mixed gangliocytoma-pituitary adenoma. This case is presented in the view of its rarity and interesting possible histogeneses.
Acromegaly
;
Adenoma*
;
Adult
;
Amenorrhea
;
Brain
;
Brain Neoplasms
;
Female
;
Galactorrhea
;
Ganglioneuroma
;
Humans
;
Pituitary Neoplasms
;
Pregnancy
9.Risperidone-induced Hyperprolactinemia.
Young Chul CHUNG ; Hong Bae EUN
Korean Journal of Psychopharmacology 1998;9(2):193-196
We experienced 6 cases of risperidone-induced hyperprolactinemia. Their mean age were 31.2+/- 7.1 years and 1 case was male and 5 cases were females. The reported neuroendocrine side effects were amenorrhea, galactorrhea and gynecomastia. The prolactin levels checked at the reported time of side effects or early stage of drug trial were more than 10 fold of normal level (male : 7.3-16.1 ng/ml, female 7.8-19.6 ng/ml). In male patient with the side effect of gynecomastia, we reduced the dose of risperidone from 6 to 3mg/day which eliminated the symptom 3 month later. As far female patients, risperidone was replaced with the equivalent doses of thioridazine or haloperidol except one female patient to whom risperione was stopped and benzodiazepine was only given. Follow-up results of them were : 1) one female patient was dropped out and 2) the others were all recovered from their neuroendocrine side effects after 3-4 months later.
Amenorrhea
;
Benzodiazepines
;
Female
;
Follow-Up Studies
;
Galactorrhea
;
Gynecomastia
;
Haloperidol
;
Humans
;
Hyperprolactinemia*
;
Male
;
Pregnancy
;
Prolactin
;
Risperidone
;
Thioridazine
10.Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine.
Mehmet Akif CAMKURT ; Gizem GÜLPAMUK ; Ebru FINDIKLI ; Rengin ELVE
Clinical Psychopharmacology and Neuroscience 2017;15(2):181-183
Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine. In particular, we discuss the course of hyper and normoprolactinemic galactorrhea. We managed this side effect initially by dose reduction and further by switching to essitalopram. Physicians should be aware of endocrinologic side effects such as galactorrhea during the serotonin and noradrenaline reuptake inhibitor treatment.
Depression
;
Depressive Disorder, Major
;
Female
;
Galactorrhea*
;
Humans
;
Norepinephrine
;
Pregnancy
;
Prolactin
;
Serotonin
;
Venlafaxine Hydrochloride*